The effect of vitamin D on haemoglobin, patient assessed disease activity and endoscopic assessment in ulcerative colitis patients with anaemia
Keywords:Anemia, Vitamin D, Haemoglobin
Background: Anemia has a dramatic impact on patient's quality of life, yet anemia in patients with UC is still underdiagnosed and undertreated. Hepcidin has been identified to be a central regulator of iron absorption from the intestines and of plasma iron levels. In this study we evaluated the effect of vitamin D supplementation on haemoglobin levels, patient assessed disease activity and endoscopic assessment in ulcerative colitis (UC).
Methods: In this prospective, open-labeled, parallel-group, randomized, comparative clinical study, we assigned newly diagnosed cases of UC with haemoglobin levels between 8-11 gm/dL to receive either standard therapy for 12 weeks or to receive oral 4000IU vitamin D3 along with standard therapy for 12 weeks.
Results: Data from 60 patients were analyzed after 12 weeks. Supplementation with vitamin D3 significantly raised haemoglobin level in treatment group from (9.09±0.20) (Mean ± SEM) at baseline to 9.62±0.22 (Mean ± SEM) at 12 weeks. On assessment of abdominal pain with NRS scale at the end of treatment at 12 weeks the reduction in NRS score was to 3.47±0.29 in group I and to 2.23±0.21 in group II (p=0.0012) which was highly significant. There was also a statistically significant reduction in the Likert scale at the end of 4, 8 and 12 weeks in both groups. At week 12, there was no statistical difference between the two groups in improving the endoscopy score.
Conclusions: Daily high dose vitamin D supplementation is beneficial in ameliorating UC symptoms like abdominal pain and has a positive effect on haemoglobin levels.
Crohn's and Colitis Foundation of Canada. The impact of inflammatory bowel disease in Canada: Final Report and Recommendations. 2012.
Ormerod TP. Anaemia in ulcerative colitis. Proc R Soc Med. 1968;61(9):931.
Oldenburg B, Koningsberger JC, Van Berge Henegouwen GP, Van Asbeck BS, Marx JJ. Iron and inflammatory bowel disease. Aliment Pharmacol Ther. 2001;15(4):429-38.
Stein J, Hartmann F, Dignass AU. Diagnosis and management of iron deficiency anemia in patients with IBD. Nat Rev Gastroenterol Hepatol. 2010;7(11):599-610.
Erichsen K, Hausken T, Ulvik RJ, Svardal A, Berstad A, Berge RK. Ferrous fumarate deteriorated plasma antioxidant status in patients with Crohn disease. Scand J Gastroenterol. 2003;38(5):543-8.
Bacchetta J, Zaritsky JJ, Sea JL, Chun RF, Lisse TS, Zavala K et al. Suppression of iron-regulatory hepcidin by vitamin D. J Am Soc Nephrol. 2014;25(3):564-72.
Kendrick J, Targher G, Smits G, Chonchol M. 25-Hydroxyvitamin D deficiency and inflammation and their association with hemoglobin levels in chronic kidney disease. Am J Nephrol. 2009;30(1):64-72.
Reinisch W, Staun M, Bhandari S, Muñoz M. State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease. J Crohns Colitis. 2013;7(6):429-40.
Smith EM, Alvarez JA, Kearns MD, Hao L, Sloan JH, Konrad RJ et al. High-dose vitamin D3 reduces circulating hepcidin concentrations: A pilot, randomized, double-blind, placebo-controlled trial in healthy adults. Clin Nutr. 2017;36(4):980-5.
Ernst JB, Prokop S, Fuchs U, Dreier J, Kuhn J, Knabbe C et al. Randomized supplementation of 4000-IU vitamin D 3 daily vs placebo on the prevalence of anemia in advanced heart failure: the EVITA trial. Nutr J. 2017;16:1-9.
Smith EM, Jones JL, Han JE, Alvarez JA, Sloan JH, Konrad RJ et al. High-Dose Vitamin D3 administration is associated with increases in hemoglobin concentrations in mechanically ventilated critically ill adults: A pilot double-blind, randomized, placebo-controlled trial. J Parenter Enteral Nutr. 2018;42(1):87-94.
Syed S, Michalski ES, Tangpricha V, Chesdachai S, Kumar A, Prince J, et al. Vitamin D status is associated with hepcidin and hemoglobin concentrations in children with inflammatory bowel disease. Inflam Bowel Dis. 2017;23(9):1650-8.
Garcia PM, Moore J, Kahan D, Hong MY. Effects of vitamin D supplementation on inflammation, colonic cell kinetics, and microbiota in colitis: a review. Molecules. 2020;25(10):2300.
Frigstad SO, Høivik ML, Jahnsen J, Cvancarova M, Grimstad T, Berset IP et al. Pain severity and vitamin D deficiency in IBD patients. Nutrients. 2019;12(1):26.
Zielińska A, Sobolewska-Włodarczyk A, Wiśniewska-Jarosińska M, Gąsiorowska A, Fichna J, Sałaga M. The 25(OH)D3, but not 1,25(OH)2D3 levels are elevated in IBD patients regardless of vitamin D supplementation and do not associate with pain severity or frequency. Pharmaceuticals (Basel). 2021;14(3):284.
Harbord M, Annese V, Vavricka SR, Allez M, Barreiro-de Acosta M, Boberg KM et al. The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease. J Crohns Colitis. 2016;10(3):239-54.
Garg M, Hendy P, Ding JN, Shaw S, Hold G, Hart A. The effect of vitamin D on intestinal inflammation and faecal microbiota in patients with ulcerative colitis. J Crohns Colitis. 2018;12:963-72.
Goulart RA, Barbalho SM. Can vitamin D induce remission in patients with inflammatory bowel disease? Ann Gastroenterol. 2022;35(2):140-9.